In terms of market side, this report researches the Advanced Molecular Nuclear Imaging revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
The global Advanced Molecular Nuclear Imaging market size in 2023 is 4777.9 million US dollars, and it is expected to be 6858.5 million US dollars by 2030, with a compound annual growth rate of 5.3% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Advanced Molecular Nuclear Imaging market include Cardinal Health, Jubilant Pharma Holdings Inc., Novartis AG, Siemens Healthcare GmbH, and Koninklijke Philips N.V.. The share of the top 3 players in the Advanced Molecular Nuclear Imaging market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Advanced Molecular Nuclear Imaging market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. SPECT Systems accounted for XX% of Advanced Molecular Nuclear Imaging market in 2023. Hybrid PET Systems share of XX%.
Hospitals accounted for XX% of the Advanced Molecular Nuclear Imaging market in 2023. Imaging Centers accounts for XX%.
Report Includes:
This report presents an overview of global market for Advanced Molecular Nuclear Imaging. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Advanced Molecular Nuclear Imaging, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Advanced Molecular Nuclear Imaging, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Advanced Molecular Nuclear Imaging market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Advanced Molecular Nuclear Imaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Advanced Molecular Nuclear Imaging sales, projected growth trends, technology, application and end-user industry.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Advanced Molecular Nuclear Imaging market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the Advanced Molecular Nuclear Imaging industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global Advanced Molecular Nuclear Imaging market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia Pacific and Middle East and Africa Advanced Molecular Nuclear Imaging market type, application and country market segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed Advanced Molecular Nuclear Imaging market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
Cardinal Health
Jubilant Pharma Holdings Inc.
Novartis AG
Siemens Healthcare GmbH
Koninklijke Philips N.V.
General Electric Company
Neusoft Corporation
Mediso Ltd.
Types list
SPECT Systems
Hybrid PET Systems
Planar Scintigraphy
Application list
Hospitals
Imaging Centers
Academic and Research Centers
List of Tables and Figures
Figure Advanced Molecular Nuclear Imaging Picture
Table Product Definition of Advanced Molecular Nuclear Imaging
Table Global Advanced Molecular Nuclear Imaging Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Advanced Molecular Nuclear Imaging Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Table Global Advanced Molecular Nuclear Imaging Market by Region: 2019 VS 2024 VS 2030
Figure Global Advanced Molecular Nuclear Imaging Revenue Market Size & Forecasts 2019-2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Advanced Molecular Nuclear Imaging Revenue by Players (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Advanced Molecular Nuclear Imaging in 2024
Figure Top 10 Largest Players of Advanced Molecular Nuclear Imaging in 2024
Table Global Advanced Molecular Nuclear Imaging Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Advanced Molecular Nuclear Imaging Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Cardinal Health Overview
Table Cardinal Health Revenue, Gross, Gross Margin 2019-2024
Table Cardinal Health Related Developments
Table Company Profiles
Table Jubilant Pharma Holdings Inc. Overview
Table Jubilant Pharma Holdings Inc. Revenue, Gross, Gross Margin 2019-2024
Table Jubilant Pharma Holdings Inc. Related Developments
Table Company Profiles
Table Novartis AG Overview
Table Novartis AG Revenue, Gross, Gross Margin 2019-2024
Table Novartis AG Related Developments
Table Company Profiles
Table Siemens Healthcare GmbH Overview
Table Siemens Healthcare GmbH Revenue, Gross, Gross Margin 2019-2024
Table Siemens Healthcare GmbH Related Developments
Table Company Profiles
Table Koninklijke Philips N.V. Overview
Table Koninklijke Philips N.V. Revenue, Gross, Gross Margin 2019-2024
Table Koninklijke Philips N.V. Related Developments
Table Company Profiles
Table General Electric Company Overview
Table General Electric Company Revenue, Gross, Gross Margin 2019-2024
Table General Electric Company Related Developments
Table Company Profiles
Table Neusoft Corporation Overview
Table Neusoft Corporation Revenue, Gross, Gross Margin 2019-2024
Table Neusoft Corporation Related Developments
Table Company Profiles
Table Mediso Ltd. Overview
Table Mediso Ltd. Revenue, Gross, Gross Margin 2019-2024
Table Mediso Ltd. Related Developments
Figure Global Advanced Molecular Nuclear Imaging Market Revenue 2019-2024
Table Global Advanced Molecular Nuclear Imaging Revenue by Region (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue Share by Region (2019-2024)
Figure Americas Advanced Molecular Nuclear Imaging Revenue (2019-2024)
Figure Europe Advanced Molecular Nuclear Imaging Revenue (2019-2024)
Figure Asia-Pacific Advanced Molecular Nuclear Imaging Revenue (2019-2024)
Figure Middle East & Africa Advanced Molecular Nuclear Imaging Revenue (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue by Type (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue Share by Type (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue by Application (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Revenue Share by Application (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue by Type (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue Share by Type (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue by Application (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue Share by Application (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue by Country (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Revenue Share by Country (2019-2024)
Figure United States Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Canada Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Mexico Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Brazil Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Argentina Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue by Type (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue Share by Type (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue by Application (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue Share by Application (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue by Country (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Revenue Share by Country (2019-2024)
Figure Germany Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure France Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure U.K. Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Italy Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Russia Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue by Type (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue Share by Type (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue by Application (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue Share by Application (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue by Region (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Revenue Share by Region (2019-2024)
Figure China Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Japan Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure South Korea Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure India Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Southeast Asia Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Australia Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue by Type (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue Share by Type (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue by Application (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue Share by Application (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue by Country (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Revenue Share by Country (2019-2024)
Figure Turkey Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure Saudi Arabia Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Figure U.A.E Advanced Molecular Nuclear Imaging Revenue Market Size (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Forecasted Revenue by Type (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Forecasted Revenue Share by Type (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Forecasted Revenue by Application (2019-2024)
Table Global Advanced Molecular Nuclear Imaging Forecasted Revenue Share by Application (2019-2024)
Figure Global Advanced Molecular Nuclear Imaging Market Revenue Forecasts 2024-2030
Table Global Advanced Molecular Nuclear Imaging Forecasts Revenue by Region (2024-2030)
Table Global Advanced Molecular Nuclear Imaging Forecasts Revenue Share by Region (2024-2030)
Figure Americas Advanced Molecular Nuclear Imaging Forecasts Revenue and Growth (2024-2030)
Table Americas Advanced Molecular Nuclear Imaging Forecasts Revenue by Country (2019-2024)
Table Americas Advanced Molecular Nuclear Imaging Forecasts Revenue Share by Country (2019-2024)
Figure Europe Advanced Molecular Nuclear Imaging Forecasts Revenue and Growth (2024-2030)
Table Europe Advanced Molecular Nuclear Imaging Forecasts Revenue by Country (2019-2024)
Table Europe Advanced Molecular Nuclear Imaging Forecasts Revenue Share by Country (2019-2024)
Figure Asia-Pacific Advanced Molecular Nuclear Imaging Forecasts Revenue and Growth (2024-2030)
Table Asia Pacific Advanced Molecular Nuclear Imaging Forecasts Revenue by Country (2019-2024)
Table Asia Pacific Advanced Molecular Nuclear Imaging Forecasts Revenue Share by Country (2019-2024)
Figure Middle East & Africa Advanced Molecular Nuclear Imaging Forecasts Revenue and Growth (2024-2030)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Forecasts Revenue by Country (2019-2024)
Table Middle East and Africa Advanced Molecular Nuclear Imaging Forecasts Revenue Share by Country (2019-2024)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report